Trial Profile
A Planned Phase II Trial of VPI 2690B
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2015
Price :
$35
*
At a glance
- Drugs VPI 2690B (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Sponsors Vascular Pharmaceuticals
- 05 Mar 2015 New trial record